Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia
Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
In this randomized clinical trial (RCT) the investigators are trying to find out whether a
low-dose therapy with daily short infusions of urokinase using 10 to 21 doses over a maximum
of 30 days is capable of prolonging the survival time without major amputation.